How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Oil drops as Trump calms Iran fears; tech stocks slide in Asia
Bank Negara's OPR expected to remain at 2.75% throughout 2026 - BMI
Ringgit edges up as softer US yields weigh on greenback�
Global trade finance gap at US$2.5 trillion as global trade tensions rise, ADB says
FBM KLCI hovers above 1,700 support
Former army chief Zamrose resigns as Boustead Heavy Industries director
Trading ideas: Sunview, TNB, Capital A, Keyfield, TRC, Rexit, Pestec, AirAsia X, Hibiscus, Selangor Dredging, BHIC, Globetronics
Oil reverses gains after Trump eases worries over Iran
Wall Street ends lower, led by drop in Nasdaq
Czech ammunition-maker CSG plans Amsterdam IPO

Others Also Read